Ovulation rate, zygote recovery and follicular populations in FSH-superovulated goats treated with PGF and/or GnRH

R. L. Krisher, F. C. Gwazdauskas, R. L. Page, C. G. Russell, R. S. Canseco, A. E.T. Sparks, W. H. Velander, J. L. Johnson, R. E. Pearson

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Follicular development and ovulation were examined in superovulated Nubian and Nubian-cross dairy goats following prostaglandin F (PGF) and/or gonadotropin releasing hormone (GnRH) treatment. Estrus was synchronized with Synchromate-B® implants. Superovulation was induced with follicle stimulating hormone (FSH) and augmented with GnRH and/or PGF. The PGF treatment was administered on Day 2 of superovulation. Implants were removed from all goats on Day 3 of superovulation. The GnRH treatment was administered 24 h after implant removal. All does were exposed to fertile males for 48 h at the time of GnRH injection. Surgical embryo recovery and ovarian response evaluation were conducted 64 to 78.5 h after implant removal. The number of ovulations was higher with GnRH treatment (18.5 ± 7; x ± SEM) than that in the controls (5.3 ± 4.1; P < 0.05). There were fewer follicles in the GnRH-treated does than in the untreated does (10.9 ± 2.9 vs 22.1 ± 3.2; P < 0.05). The number of follicles smaller than 4 mm in diameter (5.8 ± 0.8) did not differ between treatments. The GnRH-treated does had fewer 4- to 8-mm follicles (4.2 ± 2.0 vs 9.1 ± 1.6; P < 0.05) and fewer follicles larger than 8 mm (0.7 ± 1.4 vs 7.3 ± 1.6; P < 0.01) than the controls. Predicted times for 1- and 2-cell embryo recoveries were 68.5 and 73.7 h following implant removal, respectively. This study demonstrates that GnRH is an effective supplement used with FSH superovulation regimens in dairy goats. Moreover, GnRH provides for enhanced early embryo collection for DNA microinjection studies.

Original languageEnglish (US)
Pages (from-to)491-498
Number of pages8
JournalTheriogenology
Volume41
Issue number2
DOIs
StatePublished - Feb 1994

Fingerprint

Dinoprost
Zygote
follicle-stimulating hormone
Follicle Stimulating Hormone
zygote
gonadotropin-releasing hormone
Ovulation
Goats
Gonadotropin-Releasing Hormone
prostaglandins
ovulation
goats
Superovulation
superovulation
Population
Nubian (goat breed)
embryo (animal)
Embryonic Structures
dairy goats
Therapeutics

Keywords

  • GnRH
  • PGF
  • goat
  • superovulation

ASJC Scopus subject areas

  • Small Animals
  • Food Animals
  • Animal Science and Zoology
  • Equine

Cite this

Krisher, R. L., Gwazdauskas, F. C., Page, R. L., Russell, C. G., Canseco, R. S., Sparks, A. E. T., ... Pearson, R. E. (1994). Ovulation rate, zygote recovery and follicular populations in FSH-superovulated goats treated with PGF and/or GnRH. Theriogenology, 41(2), 491-498. https://doi.org/10.1016/0093-691X(94)90085-W

Ovulation rate, zygote recovery and follicular populations in FSH-superovulated goats treated with PGF and/or GnRH. / Krisher, R. L.; Gwazdauskas, F. C.; Page, R. L.; Russell, C. G.; Canseco, R. S.; Sparks, A. E.T.; Velander, W. H.; Johnson, J. L.; Pearson, R. E.

In: Theriogenology, Vol. 41, No. 2, 02.1994, p. 491-498.

Research output: Contribution to journalArticle

Krisher, RL, Gwazdauskas, FC, Page, RL, Russell, CG, Canseco, RS, Sparks, AET, Velander, WH, Johnson, JL & Pearson, RE 1994, 'Ovulation rate, zygote recovery and follicular populations in FSH-superovulated goats treated with PGF and/or GnRH', Theriogenology, vol. 41, no. 2, pp. 491-498. https://doi.org/10.1016/0093-691X(94)90085-W
Krisher, R. L. ; Gwazdauskas, F. C. ; Page, R. L. ; Russell, C. G. ; Canseco, R. S. ; Sparks, A. E.T. ; Velander, W. H. ; Johnson, J. L. ; Pearson, R. E. / Ovulation rate, zygote recovery and follicular populations in FSH-superovulated goats treated with PGF and/or GnRH. In: Theriogenology. 1994 ; Vol. 41, No. 2. pp. 491-498.
@article{c220d3825761418ead443fb642b117c7,
title = "Ovulation rate, zygote recovery and follicular populations in FSH-superovulated goats treated with PGF2α and/or GnRH",
abstract = "Follicular development and ovulation were examined in superovulated Nubian and Nubian-cross dairy goats following prostaglandin F2α (PGF2α) and/or gonadotropin releasing hormone (GnRH) treatment. Estrus was synchronized with Synchromate-B{\circledR} implants. Superovulation was induced with follicle stimulating hormone (FSH) and augmented with GnRH and/or PGF2α. The PGF2α treatment was administered on Day 2 of superovulation. Implants were removed from all goats on Day 3 of superovulation. The GnRH treatment was administered 24 h after implant removal. All does were exposed to fertile males for 48 h at the time of GnRH injection. Surgical embryo recovery and ovarian response evaluation were conducted 64 to 78.5 h after implant removal. The number of ovulations was higher with GnRH treatment (18.5 ± 7; x ± SEM) than that in the controls (5.3 ± 4.1; P < 0.05). There were fewer follicles in the GnRH-treated does than in the untreated does (10.9 ± 2.9 vs 22.1 ± 3.2; P < 0.05). The number of follicles smaller than 4 mm in diameter (5.8 ± 0.8) did not differ between treatments. The GnRH-treated does had fewer 4- to 8-mm follicles (4.2 ± 2.0 vs 9.1 ± 1.6; P < 0.05) and fewer follicles larger than 8 mm (0.7 ± 1.4 vs 7.3 ± 1.6; P < 0.01) than the controls. Predicted times for 1- and 2-cell embryo recoveries were 68.5 and 73.7 h following implant removal, respectively. This study demonstrates that GnRH is an effective supplement used with FSH superovulation regimens in dairy goats. Moreover, GnRH provides for enhanced early embryo collection for DNA microinjection studies.",
keywords = "GnRH, PGF, goat, superovulation",
author = "Krisher, {R. L.} and Gwazdauskas, {F. C.} and Page, {R. L.} and Russell, {C. G.} and Canseco, {R. S.} and Sparks, {A. E.T.} and Velander, {W. H.} and Johnson, {J. L.} and Pearson, {R. E.}",
year = "1994",
month = "2",
doi = "10.1016/0093-691X(94)90085-W",
language = "English (US)",
volume = "41",
pages = "491--498",
journal = "Theriogenology",
issn = "0093-691X",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Ovulation rate, zygote recovery and follicular populations in FSH-superovulated goats treated with PGF2α and/or GnRH

AU - Krisher, R. L.

AU - Gwazdauskas, F. C.

AU - Page, R. L.

AU - Russell, C. G.

AU - Canseco, R. S.

AU - Sparks, A. E.T.

AU - Velander, W. H.

AU - Johnson, J. L.

AU - Pearson, R. E.

PY - 1994/2

Y1 - 1994/2

N2 - Follicular development and ovulation were examined in superovulated Nubian and Nubian-cross dairy goats following prostaglandin F2α (PGF2α) and/or gonadotropin releasing hormone (GnRH) treatment. Estrus was synchronized with Synchromate-B® implants. Superovulation was induced with follicle stimulating hormone (FSH) and augmented with GnRH and/or PGF2α. The PGF2α treatment was administered on Day 2 of superovulation. Implants were removed from all goats on Day 3 of superovulation. The GnRH treatment was administered 24 h after implant removal. All does were exposed to fertile males for 48 h at the time of GnRH injection. Surgical embryo recovery and ovarian response evaluation were conducted 64 to 78.5 h after implant removal. The number of ovulations was higher with GnRH treatment (18.5 ± 7; x ± SEM) than that in the controls (5.3 ± 4.1; P < 0.05). There were fewer follicles in the GnRH-treated does than in the untreated does (10.9 ± 2.9 vs 22.1 ± 3.2; P < 0.05). The number of follicles smaller than 4 mm in diameter (5.8 ± 0.8) did not differ between treatments. The GnRH-treated does had fewer 4- to 8-mm follicles (4.2 ± 2.0 vs 9.1 ± 1.6; P < 0.05) and fewer follicles larger than 8 mm (0.7 ± 1.4 vs 7.3 ± 1.6; P < 0.01) than the controls. Predicted times for 1- and 2-cell embryo recoveries were 68.5 and 73.7 h following implant removal, respectively. This study demonstrates that GnRH is an effective supplement used with FSH superovulation regimens in dairy goats. Moreover, GnRH provides for enhanced early embryo collection for DNA microinjection studies.

AB - Follicular development and ovulation were examined in superovulated Nubian and Nubian-cross dairy goats following prostaglandin F2α (PGF2α) and/or gonadotropin releasing hormone (GnRH) treatment. Estrus was synchronized with Synchromate-B® implants. Superovulation was induced with follicle stimulating hormone (FSH) and augmented with GnRH and/or PGF2α. The PGF2α treatment was administered on Day 2 of superovulation. Implants were removed from all goats on Day 3 of superovulation. The GnRH treatment was administered 24 h after implant removal. All does were exposed to fertile males for 48 h at the time of GnRH injection. Surgical embryo recovery and ovarian response evaluation were conducted 64 to 78.5 h after implant removal. The number of ovulations was higher with GnRH treatment (18.5 ± 7; x ± SEM) than that in the controls (5.3 ± 4.1; P < 0.05). There were fewer follicles in the GnRH-treated does than in the untreated does (10.9 ± 2.9 vs 22.1 ± 3.2; P < 0.05). The number of follicles smaller than 4 mm in diameter (5.8 ± 0.8) did not differ between treatments. The GnRH-treated does had fewer 4- to 8-mm follicles (4.2 ± 2.0 vs 9.1 ± 1.6; P < 0.05) and fewer follicles larger than 8 mm (0.7 ± 1.4 vs 7.3 ± 1.6; P < 0.01) than the controls. Predicted times for 1- and 2-cell embryo recoveries were 68.5 and 73.7 h following implant removal, respectively. This study demonstrates that GnRH is an effective supplement used with FSH superovulation regimens in dairy goats. Moreover, GnRH provides for enhanced early embryo collection for DNA microinjection studies.

KW - GnRH

KW - PGF

KW - goat

KW - superovulation

UR - http://www.scopus.com/inward/record.url?scp=0000063212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0000063212&partnerID=8YFLogxK

U2 - 10.1016/0093-691X(94)90085-W

DO - 10.1016/0093-691X(94)90085-W

M3 - Article

AN - SCOPUS:0000063212

VL - 41

SP - 491

EP - 498

JO - Theriogenology

JF - Theriogenology

SN - 0093-691X

IS - 2

ER -